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Consumption of whole-grain and sourdough breads is associated with improved glucose homeostasis. We examined the impact
of commercial breads on biomarkers of glucose homeostasis in subjects at risk for glucose intolerance. In a randomized, crossover
study, overweight or obese males ingested 11-grain, sprouted-grain, 12-grain, sourdough, or white bread on diﬀerent occasions,
matched for available carbohydrate (50g) in part 1 (n = 12) and bread mass (107g) in part 2 (n = 11), and blood glucose,
insulin and glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) were determined for 3h. In
part 1, glucose response for sprouted-grain was lower than 11-grain, sourdough, and white breads. Insulin area under the curve
(AUC) for sourdough and white was lower than 11-grain and sprouted-grain breads. GLP-1 response to sourdough was lower
than all breads. In part 2, glucose and insulin AUC for sourdough was greater than 11-grain, sprouted-grain, and 12-grain breads.
Sprouted-grain bread improved glycemia by lowering glucose response and increasing GLP-1 response. In overweight and obese
men, the glycemic response to sprouted grain bread was reduced in both parts 1 and 2 while the other whole-grain test breads did
not improve metabolic responses in the acute postprandial state.
1.Introduction
There is substantial interest in the role of dietary carbohy-
drate (CHO) in preventing and managing type 2 diabetes
(T2D) [1]. In North America, bread is the predominant
CHO-containing food, and consumption of white bread
is 5 times that of whole wheat, rye, and other dark
breads [2]. Replacing white bread with whole-grain breads
is often recommended to improve glycemic control [3].
Epidemiologic studies have reported inverse associations
between whole-grain consumption and the risk of T2D and
cardiovascular disease [4–8], and clinical studies [9, 10]h a v e
reported beneﬁcial eﬀects of whole-grain consumption on
the metabolic proﬁle of subjects with impaired glycemic
control. It has been suggested that the ﬁber content of
whole-grain foods improves glucose/insulin metabolism by
reducing the rate of CHO breakdown and absorption [11–
13].
The incretin hormones, glucose-dependent insulino-
tropicpolypeptide(GIP),andglucagon-likepeptide-1(GLP-
1) are intimately involved in postprandial regulation of
glucose homeostasis. It is estimated that approximately half
of the postprandial insulin release in response to CHO
ingestion is caused by these gut-derived hormones [14–
17]. Thus, the magnitude of the incretin response is vital
to both the acute insulinemic and glycemic responses to
CHO ingestion. However, our understanding of the impact
of diﬀerent types of CHO on the incretin response is still in
its infancy.
Previously, we showed that ingestion of whole-wheat
and whole-wheat barley breads did not result in attenuated
insulin responses compared with white bread [18]. Further-
more, sourdough white bread resulted in lower glucose and
GLP-1 responses for two subsequent meal periods [18]. In
our previous work, ultraﬁnely grounded whole-wheat ﬂour
was used rather than whole-grain ﬂour. In addition, in2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
order to equalize the amount of available CHO (50g) across
treatments, the bread mass consumed varied from 98 to
138g resulting in higher energy, fat, protein, and ﬁber intake
for the whole-wheat bread treatments [18]. Further study is
needed to examine if bread mass inﬂuences the metabolic
responses to bread.
The sprouting treatment of cereal grains is reported to
decrease starch content and increase the content and avail-
ability of vitamins, minerals, and antioxidants [19]. One
clinical study reported improved glycemia following con-
sumption of pregerminated brown rice, compared to white
rice, in healthy and type T2D subjects [20]. The metabolic
eﬀectofbreadsbakedwithsproutedwheatﬂourhasnotbeen
extensively studied.
The present investigation had a distinct applied nature
and tested the hypothesis that consumption of laboratory-
prepared sourdough bread and commercially available
whole-grainandsprouted-grainbreadswouldresultinlower
metabolicresponsescomparedwithcommercial,whitebread
in subjects who are at risk for glucose intolerance and T2D.
This hypothesis was tested using 2 approaches including
normalizing consumption of breads according to available
CHO (part 1) and bread mass (part 2).
2.MaterialsandMethods
ThestudyprotocolwasapprovedbytheUniversityofGuelph
Human Research Ethics Board and each subject provided
written informed consent. Subjects were recruited from
the Guelph, Ontario area through advertisement in local
newspapers. Subjects were overweight or obese males (body
mass index (BMI): 25–35kg/m2), nonsmokers and had no
history of gastrointestinal disease, gluten allergy, dyslipi-
demia, or diabetes. Subjects did not take medications (with
the exception of antidepressants and/or antihypertensives)
or natural health products. Potential subjects were screened
for glucose intolerance and diabetes at a prestudy visit
using a standard 2h oral glucose tolerance test (OGTT)
(Trutol Custom Laboratories Inc., Baltimore, MD). Subjects
were excluded if they had impaired fasting plasma glucose
(>6.1mmol/L), impaired glucose tolerance (>7.8mmol/L at
2h), or impaired fasting insulin (>90pmol/L).
2.1. General Protocol. Parts 1 and 2 of the investigation fol-
lowed the same protocol, with the exception of the quantity
of bread consumed. A single-blind, randomized crossover
design was used with washout periods of at least 1 week
between study days. Throughout the study, subjects were
instructed to maintain their usual diet and lifestyle but
were instructed to avoid alcohol, caﬀeine substances and
strenuous physical activity 48h prior to each study day and
to report to the laboratory after an overnight (12h) fast.
Dietary records were kept for three days prior to each study
day and in the evening before each study day, subjects were
instructed to consume a standardized meal, consisting of
vegetablelasagne(President’sChoiceBlueMenuReducedFat
Vegetable Lasagne) and a cereal bar (Kellogg’s Nutri-Grain
Cereal Bar).
Table 1: Nutrient composition of the test breads delivering 50g
available CHO (part 1)1.
11-grain Sprouted-
grain Sourdough 12-grain White
Total
bread (g) 151.0 157.2 107.3 122.2 110.3
Available
CHO (g)2 50.0 50.0 50.0 50.0 50.0
Energy
(kcal) 320.2 336.4 277.9 317.8 273.7
Starch (g) 44.9 46.3 45.4 42.5 43.6
Total
sugars (g) 5.1 3.6 4.5 7.4 6.4
Soluble
ﬁber (g) 0.9 0.6 0.3 1.1 0.3
Insoluble
ﬁber (g) 11.9 11.4 4.9 9.9 4.6
Dietary
ﬁber (g) 12.8 12.1 5.2 11.0 4.9
Protein (g) 16.9 22.3 9.0 12.6 9.8
Fat (g) 3.1 2.9 4.3 5.2 3.6
1Test breads were analyzed by Laboratories of Canada Incorporated (ILC) in
Tillsonburg, ON.
2Available CHO was calculated using this formula: starch + total sugar.
On each study day, a venous catheter was inserted into
the forearm by a trained technician and kept patent for the
duration of the experiment with a slow saline infusion. After
collection of a fasting blood sample (time point −15min),
subjects consumed a serving of test bread with 250mL of
water within 15min. The laboratory clock started when
subjects commenced eating the bread, and after 15min
(time point zero) the second blood sample was collected.
Subsequently, blood samples were collected at 15, 30, 45, 60,
90, 120, 150, and 180min.
2.1.1. Part 1: Acute Postprandial Eﬀect of Ingestion of Breads
Matched for Available Carbohydrate. Twelve overweight or
obese males were recruited in part 1. The test breads
were prepared to provide 50g of available CHO which
required portions of 151g for 11-grain (whole-grain, with
sourdoughculture,Stone-millBakehouseLtd.,Scarborough,
ON, Canada), 157g of sprouted-grain (whole-grain, with
sourdoughculture,Stone-millBakehouseLtd.,Scarborough,
ON, Canada), 107g of sourdough white (as described previ-
ously [18] and baked at the Guelph Food Technology Centre
at the University of Guelph), 122g of 12-grain (whole-grain,
Dempsters, Canada Bread Ltd., Brampton, ON, Canada),
and 110g of white bread (Wonder Bread, Weston Bakeries
Ltd., Toronto, ON, Canada) (Table 1). Breads were sliced,
decrusted and stored at −20◦C until consumption. Before
consumption, the bread slices were thawed in a microwave
oven for 15s and weighed.
2.1.2. Part 2: Acute Postprandial Eﬀect of Ingestion of Breads
Matched for Mass. Eleven overweight or obese males com-
pletedpart2,9ofwhomalsocompletedpart1.ThesametestJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
Table 2: Nutrient composition of the test breads delivering a
consistent portion size (part 2)1.
11-grain Sprouted-
grain Sourdough 12-grain White
Total
bread (g) 107.3 107.3 107.3 107.3 107.3
Available
CHO (g)2 35.5 34.0 50.0 43.8 48.6
Energy
(kcal) 227.4 229.6 277.9 278.9 266.0
Starch (g) 31.2 31.6 45.4 37.3 42.3
Total
sugars (g) 4.3 2.4 4.5 6.5 6.2
Soluble
ﬁber (g) 0.6 0.4 0.3 0.9 0.3
Insoluble
ﬁber (g) 8.4 7.8 4.9 8.6 4.5
Dietary
ﬁber (g) 9.1 8.2 5.2 9.6 4.8
Protein (g) 12.0 15.2 9.0 11.0 9.5
Fat (g) 2.2 2.0 4.2 4.6 3.5
1Test breads were analyzed by Laboratories of Canada Incorporated (ILC) in
Tillsonburg, ON.
2Available CHO was calculated using this formula: starch + total sugar.
breadsstudiedinpart1werepreparedtoprovideaconsistent
portion of 107g. This volume was selected as it allowed for
a comparison between parts 1 and 2 for the ingestion of
the same quantity of the sourdough bread. This resulted in
portions of 35, 34, 50, 43, and 48g of available CHO for 11-
grain, sprouted-grain, sourdough white, 12-grain, and white
bread, respectively (Table 2).
2.2. Blood Collection, Biochemical and Dietary Analysis. For
analysis of blood glucose, blood samples were collected at all
timepointsintovacutainerscontaining72USPunitssodium
heparin, immediately put on ice, and subsequently analyzed
using a semiautomatic glucose analyzer (YSI 2300, Yellow
Springs, OH, USA). For analysis of serum insulin, blood
samples were collected at all time points into vacutainers
without anticoagulants and centrifuged (1341×gf o r1 0m i n
at 4◦C). Serum supernatant was aliquoted and frozen at
−20◦C until analysis using a solid phase 125I radioim-
munoassay (Coat-A-Count, Diagnostic Products Corpora-
tion, CA, USA) with an intra- and interassay variability of
5.2% and 7.3%, respectively.
For analysis of the incretin hormones, blood samples
were collected at all time points into ice-chilled tubes
containing 10.8mg K2EDTA, 1824 KIU aprotinin, and 10
μL/mL blood dipeptidyl peptidase-4 inhibitor. Following
centrifugation (1000×gf o r1 5 m i na t4 ◦C), plasma was
separated and stored at −80◦C until analysis. Plasma GIP
total concentrations were measured using a Human GIP
(Total) ELISA kit (Linco Research Inc., St Charles, USA)
with 100% crossreactivity to human intact GIP, GIP (1–
42), and the N-terminally truncated metabolite, GIP (3–
42). Intra- and interassay variability for GIP were 6.5%
and 3.4%, respectively. Plasma GLP-1 total concentrations
were measured by GLP-1 total RIA kit (Linco Research Inc.,
St Charles, USA) after extraction with 70% ethanol. The
antibody used in this kit binds speciﬁcally with C-terminal
portion of GLP-1, both amidated and nonamidated forms.
Intra- and interassay variations for GLP-1 were 4.0% and
9.9%, respectively.
Food record data were analyzed for energy, macronutri-
ents, cholesterol, and dietary ﬁber by using ESHA Food Pro-
cessor program (version 9.5, Salem, OR, USA) and averaged
across each 3-day food record.
2.3. Calculations and Statistical Analysis. Incremental area
under the curve (AUC) was determined for blood glucose,
serum insulin, plasma GIP, and GLP-1 (GraphPad Prism,
version 3.02, San Diego, CA, USA). Prism computes the
incremental area under the curve by using the trapezoid rule.
Time point −15 was used as the baseline, and values below
the baseline were considered to be negative peaks. Insulin
Sensitivity Index (ISI) was calculated using the method
described by Matsuda and DeFronzo [21].
All statistical analyses were performed using the Statisti-
cal Analysis System (SAS Institute Inc., version 9.1 Cary, NC,
USA). Univariate analysis was used to examine the distribu-
tion of each variable, and logarithmic transformations were
applied to data that was not normally distributed (speciﬁc
variables are identiﬁed in data tables). Signiﬁcance (P<
0.05) was tested by two-factor repeated measure analysis of
variance (ANOVA) using a mixed model (treatment: ﬁxed
eﬀectandsubject:randomeﬀect)followedbytheTukey’stest
for multiple comparisons. Results are presented as mean ±
SEM.
3. Results
3.1. Part 1: Acute Postprandial Eﬀect of Ingestion Breads
Matched for Available CHO
3.1.1. Subjects. Twelve subjects (age: 54.9±2.0y ,B M I :2 9 .1±
1.1kg/m 2,f a s t i n gb l o o dg l u c o s e :4 .5 ± 0.1mmol/L, fasting
serum insulin: 50.8 ± 4.8pmol/L) completed part 1 of the
study.
3.1.2. Blood Glucose. Signiﬁcant overall treatment eﬀects
were found in glucose responses to the breads (Figure 1).
Sprouted-grain bread was signiﬁcantly lower than 11-grain
(P<0.009), sourdough (P<0.001), and white (P<0.006)
breads. Furthermore, 12-grain bread was signiﬁcantly lower
than 11-grain (P<0.04) and sourdough (P<0.003)
breads. Similarly, glucose incremental AUC for sprouted-
grain bread was signiﬁcantly lower than 11-grain (P<
0.007), sourdough (P<0.004), and white (P<0.05) breads
(Table 3). Furthermore, glucose incremental AUC for 12-
grain bread was signiﬁcantly lower than 11-grain (P<0.01)
and sourdough (P<0.009) breads (Table 3).
3.1.3. Serum Insulin and Insulin Sensitivity. Signiﬁcant over-
all treatment eﬀects were found in insulin responses to the4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
Table 3: Incremental area under the curve for blood glucose, serum insulin, plasma GIP and GLP-1 after ingestion of 50g available CHO of
the test breads for 180min (part 1)1,2.
11-grain Sprouted-grain Sourdough 12-grain White
Glucose (mM/L·min) 0.64a ±0.04 0.22b ±0.17 0.66a ±0.16 0.26bc ±11.00 .51ac ± 0.17
Insulin (nM/L ∗ 180min) 31.6a ±63 0 .4a ± 52 1 .4b ±3.32 5 .9ab ±6.82 4 .1b ±4.5
GIP (nM/L ∗ 180min) 3.2 ±0.43 .7 ±0.33 .6 ±0.43 .6 ±0.43 .3 ±0.2
GLP-13 (nM/L ∗ 180min) 0.58 ±0.23 0.57 ±0.32 −0.04 ±0.16 0.38 ±0.20 .41 ±0.31
1All values are mean (±SEM); (n = 12) except for GLP-1 (n = 11) because of technical problems.
2Mean values within a row with diﬀerent superscript letters were signiﬁcantly diﬀerent (P<0.05).
3Data was log-transformed prior to statistical analysis and is presented as the geometric mean ± SEM.
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Figure 1: Fasting and postprandial glucose responses to the
ingestion of 50g available carbohydrate of the test breads. Data are
means. Standard errors are not included for clarity, n = 12. Test
bread was ingested after collection of fasting blood sample at time
point −15min. Signiﬁcant overall treatment eﬀects were found in
glucose responses to the breads (Sprouted-grain bread was lower
than 11-grain (P<0.009), sourdough (P<0.001), and white
(P<0.006) breads). Twelve-grain bread was lower than 11-grain
(P<0.04) and sourdough (P<0.003) breads).
breads with 11-grain bread being higher than sourdough
(P<0.005) and white (P<0.03) breads (Figure 2).
Furthermore, insulin incremental AUC for 11-grain and
sprouted-grain breads was signiﬁcantly (P<0.05) greater
than sourdough and white breads (Table 3). ISI was not
signiﬁcantly diﬀerent among the breads (data not shown).
3.1.4. Plasma GIP and GLP-1. Despite the diﬀerence in
insulin responses, there was no signiﬁcant overall treatment
eﬀect in GIP responses to the breads (data not shown).
Similarly, bread treatment did not signiﬁcantly aﬀect GIP
incremental AUC (Table 3). The signiﬁcant diﬀerences in
overall GLP-1 response to the breads did not correspond
with those for insulin. The GLP-1 response to sourdough
bread was lower than 11-grain (P<0.0001), sprouted-grain
(P<0.0001), and white (P<0.02) breads. Additionally, the
GLP-1 response to 11-grain bread was greater than 12-grain
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Figure 2:Fastingandpostprandialinsulinresponsetotheingestion
of 50g available carbohydrate of the test breads. Data are means.
Standard errors are not included for clarity, n = 12. Test bread
was ingested after collection of fasting blood sample at time point
−15min. Signiﬁcant overall treatment eﬀects were identiﬁed (11-
grain bread was greater than sourdough (P<0.005) and white
(P<0.03) breads).
(P<0.03) and white (P<0.03) breads, while the GLP-1
response to sprouted-grain bread was greater than 12-grain
(P<0.009) and white (P<0.05) breads (Figure 3). Despite
these diﬀerences, bread treatment did not signiﬁcantly aﬀect
GLP-1 incremental AUC (Table 3).
3.2. Part 2: Acute Postprandial Eﬀect of Ingestion of Breads
Matched for Mass
3.2.1. Subjects. Eleven subjects (age: 53.9±1.7y ,B M I :2 8 .6±
0.7kg/m 2, fasting glucose: 4.6 ± 0.1mmol/L, fasting insulin:
40.6 ±5.7pmol/L) completed part 2 of the study.
3.2.2. Blood Glucose. Although there were no signiﬁcant
overall treatment eﬀects in glucose responses to the breads,
glucose incremental AUC for sourdough bread was signif-
icantly greater than 11-grain (P<0.002), sprouted-grain
(P<0.01),12-grain(P<0.001),andwhite(P<0.04)breads
(Table 4).J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
Table 4: Incremental area under the curve for blood glucose, serum insulin, plasma GIP and GLP-1 responses to the ingestion of set amount
of the test breads for 180min (part 2)1,2.
11-grain Sprouted-grain Sourdough 12-grain White
Glucose (mM/L·min) 0.31a ±0.12 0.17a ±0.15 0.72b ±0.19 0.41a ±0.11 0.46a ± 0.14
Insulin (nM/L ∗ 180min) 16.2ac ±2.11 2 .7ac ±1.92 1 .5b ±2.71 6 .8a ±2.41 8 .1bc ±3.4
GIP (nM/L ∗ 180min) 2.7a ±0.33 .1ab ±0.33 .5bc ±0.33 .3ac ±0.44 .0b ±0.7
GLP-13(pM/L ∗ 180min) 0.48ab ± 0.20 .83a ± 0.3 −0.05b ±0.1 −0.19b ±0.50 .07ab ±0.3
1All values are mean (±SEM); (n = 11) except for GLP-1 (n = 10) because of technical problems.
2Mean values within a row with diﬀerent superscript letters were signiﬁcantly diﬀerent (P<0.05).
3Data was log transformed prior to statistical analysis and is presented as the geometric mean ± SEM.
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Figure 3: Fasting and postprandial GLP-1 responses to the inges-
tion of 50g available carbohydrate of the test breads. Data are
means. Standard errors are not included for clarity, n = 11. Test
bread was ingested after collection of fasting blood sample at time
point −15min. Signiﬁcant overall treatment eﬀects were found
(sourdough bread was lower than 11-grain (P<0.0001), sprouted-
grain (P<0.0001), and white (P<0.02) breads. 11-grain bread
was greater than 12-grain (P<0.03) and white (P<0.03) breads.
Sprouted-grain bread was greater than 12-grain (P<0.009) and
white (P<0.05) breads).
3.2.3. Serum Insulin and Insulin Sensitivity. Signiﬁcant over-
all treatment eﬀects were found in insulin responses to
the breads with sprouted-grain being lower than 12-grain
(P<0.03) bread and 12-grain bread being lower than
sourdough (P<0.001) and white (P<0.001) breads
(Figure 4). Insulin incremental AUC for 11-grain (P<0.03),
sprouted-grain (P<0.05), and 12-grain (P<0.0007) breads
was signiﬁcantly lower than sourdough bread. In addition,
insulin incremental AUC for 12-grain was lower than white
bread (P<0.03) (Table 4). ISI was not signiﬁcantly diﬀerent
among the breads (data not shown).
3.2.4.PlasmaGIPandGLP-1. Asinpart1,incretinresponses
did not correspond with the postprandial insulin response.
Overall GIP response to 11-grain was lower than sourdough
bread (P<0.008) (Figure 5). GIP incremental AUC for 11-
grain bread was signiﬁcantly lower than sourdough (P<
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Figure 4: Fasting and postprandial insulin responses to the inges-
tion of a consistent amount of the test breads. Test bread was
ingested after collection of fasting blood sample at time point
−15min. Data are means. Standard errors are not included for
clarity, n = 11. Signiﬁcant overall treatment eﬀects were found
in insulin response to the breads (sprouted-grain bread was lower
than 12-grain (P<0.03) bread, and 12-grain bread was lower than
sourdough (P<0.001) and white (P<0.001) breads).
0.03) and white (P<0.001) breads (Table 4). Despite the
modest (4.8g) diﬀerence in the available CHO consumed,
GIP incremental AUC for 12-grain was lower than white
bread (P<0.03) (Table 4).
Similarly, GLP-1 response did not relate to the amount
of available CHO consumed as the overall GLP-1 response
to sprouted-grain bread was signiﬁcantly greater than 11-
grain (P<0.008), sourdough (P<0.001), 12-grain
(P<0.04), and white (P<0.04) breads (Figure 6). GLP-1
incrementalAUCforsprouted-grainwassigniﬁcantlygreater
than sourdough (P<0.05) and 12-grain (P<0.01) breads
(Table 4).
4. Discussion
The purpose of the current study was to determine the
acute eﬀects of breads of variable carbohydrate composition
on postprandial glucose, insulin, and incretin responses
in sedentary, overweight/obese males as this population6 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 5: Fasting and postprandial GIP responses to the ingestion
of a consistent amount of the test breads. Data are means. Standard
errors are not included for clarity, n = 11. Test bread was ingested
after collection of fasting blood sample at time point −15min. A
signiﬁcant overall treatment eﬀect was found (11-grain bread was
lower than sourdough (P<0.008) bread).
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Figure 6: Fasting and postprandial GLP-1 responses to the inges-
tion of a consistent amount of the test breads. Data are means.
Standard errors are not included for clarity, n = 10. Test bread
was ingested after collection of fasting blood sample at time
point −15min. Signiﬁcant overall treatment eﬀects were found
(sprouted-grain bread was greater than 11-grain (P<0.008),
sourdough (P<0.001), 12-grain (P<0.04), and white (P<0.04)
breads).
represents a group that are at increased risk for T2D.
We hypothesised that the sprouted-grain, whole-grain, and
sourdough breads would lower the postprandial metabolic
responses, in comparison to white bread, in both parts 1
and 2 of the study. The nature of the subjects and the
testing of commercial breads given either in portions based
on available CHO or volume are limitations to interpreting
the data, but they also are a strength as the ﬁndings are
very applicable to society. The key ﬁndings were that the
sprouted grain bread reduced the glycemic responses in both
parts of the study and also that generally the whole-grain
breads did not have what could be interpreted as beneﬁcial,
metabolic responses. While some diﬀerences were observed
in the incretin hormones, these did not correspond to the
insulin responses.
When 50g of available CHO was ingested (part 1), the
glucoseresponse(overallandincrementalAUC)tosprouted-
grain bread was signiﬁcantly less than 11-grain, sourdough,
and white breads. Additionally, the glucose response (overall
and incremental AUC) for 12-grain bread was signiﬁcantly
lower than sourdough and 11-grain breads. The favourable
glucose responses to the sprouted-grain and 12-grain breads
support our hypothesis. Greater ﬁber content in sprouted-
grain and 12-grain breads (Table 1) may explain the lowered
glycemia following their ingestion compared to white and
sourdough breads. Dietary ﬁber is reported to attenuate
glycemic response through its physical action in the gut
which lowers the rate of CHO digestion and absorption
[11, 12, 21–23]. However, the glucose-lowering eﬀect of
cereal ﬁber has been attributed primarily to soluble ﬁber
[12, 22, 24], and in the present study, the ﬁber content of
the sprouted-grain and 12-grain breads was predominantly
insoluble ﬁber, suggesting that soluble ﬁber may not be the
only component responsible for improving glycemia. Other
nutrients and components in the sprouted-grain and 12-
grain breads may also have positive health-related eﬀects.
It has been suggested that the sprouting treatment of cereal
grainsincreasesthecontentandavailabilityofvitamins,min-
erals, and antioxidants [19], and whole-grains are known to
contain higher amounts of vitamins, minerals, antioxidants,
and phytochemicals. The presence of micronutrients such as
magnesium, vitamin E, antioxidants, phenolic compounds,
and phytoestrogens may act synergistically to lower glycemia
[6–9, 25, 26].
The lack of signiﬁcant diﬀerence in postprandial glu-
cose response between the 11-grain and white bread was
unexpected. It should be noted that there are several factors
inﬂuencing the metabolic responses to breads including the
ﬂour particle size, kneading protocol, leavening process, and
baking procedure [27–31], but we are currently unable to
identify which speciﬁc factor may have accounted for the
ﬁndings in the present study. A strength of this study is its
applicability due to the use of commercially prepared breads,
but this also presents a limitation as detailed information
regarding ingredients (i.e., the grain/ﬂour structure and
proportion contribution to each bread) and processing tech-
niques are not available. Furthermore, although we accept
that sample size may be another limitation, our results
strongly suggest that there are no acute metabolic diﬀerences
among the other breads. However, this does not mean there
are no beneﬁts in consuming these breads rather that any
of the beneﬁts are not obvious within the few hours that
we studied. In fact, large epidemiological studies show an
inverse relationship with whole grain intake and risk of
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examining almost 43000 people for up to 12 years found
that a diet high in whole grains was inversely associated
with type 2 diabetes risk [5]. Although the physiological
mechanisms remain unclear, the postprandial response to
dietary ﬁber remains a promising mediator of improved
health. Conversely, a small randomized crossover study with
30 subjects by Andersson and colleagues [32] aligns with
our results suggesting a lack of a favorable postprandial
metabolicresponsetowholegrainwhencomparedtoreﬁned
meals in those who are healthy and slightly overweight.
Overall, there is paucity of information on the metabolic
responses to breads of varying carbohydrate in overweight
and obese men, and investigation with larger sample sizes is
warranted to better understand the biological mediators of
glycemic control.
While it is possible that any positive eﬀect of the 11-grain
bread would be apparent only after a chronic intervention,
ourﬁndingsclearlyhighlightthatwhole-grainbreadsarenot
the same. Eleven-grain bread was prepared with sourdough
culture and contained high amount of ﬁber and did not
improve glycemia; this ﬁnding suggests that one cannot
generalize across whole-grain products, and the metabolic
responses to whole-grains are diﬀerent for each recipe.
The insulin results did not support our hypothesis.
WhenmatchedforavailableCHO,insulinincrementalAUCs
for 11-grain and sprouted-grain breads were greater than
sourdoughandwhitebreads(Table 3).Thisisconsistentwith
the glucose data for sprouted-grain and sourdough breads,
but does not explain the glucose result for 11-grain bread,
suggestingthatglycemiadoesnotalwayspredictinsulinemia.
In the present study, acute ingestion of 50g available
CHO from whole-grain and sprouted-grain breads did
not improve insulinemia or insulin sensitivity (as assessed
by calculation of ISI) compared to white bread. Limited
literature is available on acute intervention and the results
from epidemiologic [4, 5, 7] and chronic interventional
[9, 10] studies suggest that any positive eﬀect of whole-grain
food intake on insulinemia and insulin sensitivity is only
apparent after a chronic intervention. These ﬁndings may
help explain the lack of positive eﬀect of acute ingestion of
whole-grain breads on insulinemia and insulin sensitivity in
our study.
It should be noted that the magnitude of the glucose and
insulin (Tables 3 and 4) responses to the sourdough bread
was similar in parts 1 and 2 of the study, respectively, and
that these data are consistent with those reported previously
from our laboratory [18]. While we previously showed that
sourdough bread resulted in a more favourable postprandial
response compared with whole-wheat bread [18], the breads
were all prepared in the laboratory. In the present study, the
comparison was with whole-grain (not whole-wheat) breads
that were commerciallyprepared. In the former investigation
[18], the breads were all administered to control for available
CHO and thus subjects ingested diﬀerent amounts of breads.
In part 2 of the current study, matching the treatments for
volume of bread consumed resulted in a large diﬀerence in
available CHO content among the breads. The lower glucose
and insulin incremental AUCs for the whole-grain breads
compared to those of sourdough bread can be attributed to
the lower available CHO and greater dietary ﬁber content of
the whole-grain treatments.
Incretins are potent insulin-releasing hormones that play
an important role in glucose homeostasis. Previously we
observed that sourdough bread resulted in lower GLP-1
response [18]. In part 1 of the present study, GIP responses
to the ingestion of 50g available CHO of the breads did not
diﬀer signiﬁcantly among the test breads. However, in part
2, ingestion of equal amounts of the test breads resulted in
signiﬁcantly lower GIP incremental AUC for 11-grain and
12-grain breads compared to white breads, a result that may
be attributed to the lower available CHO content of these
breads. However, the GIP response to sprouted-grain bread,
with the lowest available CHO content, was not lower than
those to white bread. In both parts 1 and 2, the insulin
responsesdidnotappeartofollowthatoftheincretins.These
ﬁndings suggest that postprandial responses for diﬀerent
whole-grain breads are complex and cannot be explained
only by the available CHO content.
Consistent with our previous study [18], in part 1 of the
present study, overall GLP-1 response to sourdough bread
was signiﬁcantly lower than 11-grain, sprouted-grain, and
white breads. Consistently, insulin response to sourdough
bread in part 1 was signiﬁcantly lower than 11-grain and
sprouted-grain breads. Bakhoj et al. [33]r e p o r t e dl o w e r e d
postprandial GIP responses to the ingestion of Einkorn
honey-salt leavened and whole-grain breads compared to the
conventional yeast bread and proposed that this was due
to an increased level of organic acids (based on reduction
of the pH in the dough). Dietary ﬁber has also been
shown to increase GLP-1 secretion in rats [34]a n dd o g s
[35]. A study by Massimino et al. [35] found that highly
fermentable dietary ﬁbers were more potent stimulators of
GLP-1 secretion compared to low fermentable ﬁbers. Given
that the fermentable, insoluble ﬁbre content was greatest in
the sprouted-grain and lowest in the sourdough bread, it is
reasonable to speculate that the GLP-1 response observed in
thepresentstudymayin partbeinﬂuencedbyinsoluble ﬁber
content of the breads. Lastly, it is important to note that a
more reﬁned study of incretin dynamics in an animal model
may better characterize the transient postprandial nature of
these peptides taking into account their relatively short half-
lives. In our study, however, we were ethically constrained
and only able to draw a certain number of samples that were
mixed venous in nature thus why we opted to examine the
incretin response as incremental AUC.
Overall, the results of the current investigation suggest
that glucose metabolism is complex and multifactorial. The
simple model of glucose stimulated insulin secretion, and
incretins regulating postprandial insulin release does not
always apply. Additionally, GIP and GLP-1 do not respond
in a similar manner with respect to the CHO ingested. In our
previous [18] and present studies, we showed that the nature
of the bread consumed has an impact on glucose, insulin,
and incretin responses, but the mechanism is complex and
requires further investigation.
To our knowledge, this is the ﬁrst study to compare
postprandial responses to ingestion of various breads deliv-
ering an identical amount of available CHO (thus diﬀerent8 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
masses) with the postprandial eﬀect of ingestion of a ﬁxed
portion size (thus same volume, but diﬀerent amounts of
available CHO) of the same breads in overweight/obese men.
It appears that bread volume and ﬁber content may play a
role but are not the dominant factors in determining the
metabolic responses to the breads, as in part 2 of the study,
11-grain, sprouted-grain, and 12-grain breads, with similar
volume and ﬁber content, induced diﬀerent results in almost
every measure. These results suggest that the nature of the
ingredients is an important factor inﬂuencing the metabolic
responses to the breads. Lack of diﬀerence between 11-grain
and white breads was unexpected but it may be that any
positive impact of 11-grain on glucose metabolism only
occurs after a chronic dietary intervention.
5. Conclusion
While the study is limited due to its applied nature (i.e.,
employing commercial breads and a somewhat heteroge-
neous subject set), this is also a strength in terms of applying
the ﬁndings to the lifestyle of society. Despite the variation
that these factors produced, the investigation demonstrated
that sprouted grain bread attenuated the glycemic response
when both portion size and available carbohydrate were
controlled for and that, generally, the whole-grain breads did
not have what could be interpreted as beneﬁcial, metabolic
responses.
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